http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20983493

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 635
issn 0091-2700
1552-4604
issueIdentifier 5
pageRange 629-635
publicationName The Journal of Clinical Pharmacology
startingPage 629
bibliographicCitation Sato K, Mano T, Iwata A, Toda T. Subtype‐Dependent Reporting of Stroke With SGLT2 Inhibitors: Implications From a Japanese Pharmacovigilance Study. The Journal of Clinical Pharma. 2019 Dec 02;60(5):629–35. doi: 10.1002/jcph.1561.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7308-5314
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c32586e83f434f9a3f70a58b4986099
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfad311e714456d616475353c6d1f026
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82dad9ba1faa1c60139dd9505476eaa6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd38f0a2882699f8c215f8a3ca491482
date 2019-12-02^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1002/jcph.1561
https://pubmed.ncbi.nlm.nih.gov/31792991
isPartOf https://portal.issn.org/resource/ISSN/0091-2700
https://portal.issn.org/resource/ISSN/1552-4604
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4646
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Subtype‐Dependent Reporting of Stroke With SGLT2 Inhibitors: Implications From a Japanese Pharmacovigilance Study
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11346
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7559
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10657
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95245167042cebb599d71e1a81bf6d4
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6749
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Showing number of triples: 1 to 33 of 33.